Why is Bafna Pharma. falling/rising?

As of 19-Nov, Bafna Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 170.50, which reflects a decrease of 3.48 or 2.0%. The stock has been underperforming significantly, having lost value for the last five consecutive days, resulting in a total return of -100% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, investor participation has decreased sharply, with delivery volume dropping by 89.59% compared to the 5-day average, suggesting a lack of interest from investors. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's movement.
In the broader market context, Bafna Pharmaceuticals has underperformed relative to the benchmark index, the Sensex, which has gained 0.68% over the past week while Bafna's stock has declined by 9.62%. Despite a strong year-to-date performance of 116.10%, the recent short-term trends indicate a significant downturn, contrasting sharply with the benchmark's modest growth. This divergence highlights the stock's current struggles despite its previous strong performance, suggesting that recent market sentiment may be weighing heavily on Bafna Pharmaceuticals' stock price.